Notably, in preclinical research related to OC, suppressing the expression of CD47 and CD24 or blocking them with anti-CD47 and anti-CD24 mAbs was found to enhance macrophage-mediated phagocytosis, thus resulting in a significant reduction in the growth of xenograft tumours [7, 44]. This evidence concerns the gene CD47 and neoplasm.